Jefferies Downgrades Express Scripts (ESRX) to Hold Post Q3 and Downbeat Outlook
Tweet
Share
E-mailGet Alerts ESRX Hot Sheet
Price: $92.33 --0%
Rating Summary:
6 Buy, 20 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Rating Summary:
6 Buy, 20 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Join SI Premium – FREE
Jefferies downgraded Express Scripts (NASDAQ: ESRX) from Buy to Hold with a price target of $56.00 (from $70.00) following Q3 results and downbeat guidance.
The firm comments, "We are downgrading ESRX to Hold from Buy after mgmt commented last night that 2013 Street EPS expectations (currently at 21% Y/Y growth) are overly aggressive. While we had anticipated ESRX's growth rate to decelerate after synergies from its Medco acquisition are realized, it appears that ESRX is reaching its maturity point quicker than most investors had expected."
FY12 EPS goes up from $3.72 to $3.74 and FY13 goes down from $4.51 to $4.25.
For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.
Shares of Express Scripts closed at $62.02 yesterday.
The firm comments, "We are downgrading ESRX to Hold from Buy after mgmt commented last night that 2013 Street EPS expectations (currently at 21% Y/Y growth) are overly aggressive. While we had anticipated ESRX's growth rate to decelerate after synergies from its Medco acquisition are realized, it appears that ESRX is reaching its maturity point quicker than most investors had expected."
FY12 EPS goes up from $3.72 to $3.74 and FY13 goes down from $4.51 to $4.25.
For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.
Shares of Express Scripts closed at $62.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lam Research (LRCX) PT Lowered to $850 at Susquehanna
- Meta Platforms Inc. (META) PT Lowered to $500 at Baird
- CME Group (CME) PT Raised to $187 at Rosenblatt
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
